Search

Your search keyword '"Hunter, James R."' showing total 112 results

Search Constraints

Start Over You searched for: Author "Hunter, James R." Remove constraint Author: "Hunter, James R."
112 results on '"Hunter, James R."'

Search Results

3. Medriders: Refueling in flight

4. Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial

5. People living with HIV co‐infected with the Kaposi Sarcoma‐associated Herpes Virus have a distinct HIV Tat profile and higher rates of antiretroviral virologic failure, more evident among those with Kaposi's sarcoma.

7. Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.

10. Effective phage cocktail to combat the rising incidence of extensively drug-resistant Klebsiella pneumoniae sequence type 16

11. Additional file 7 of Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial

12. Additional file 6 of Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial

13. Additional file 3 of Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial

14. Additional file 2 of Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial

15. Additional file 11 of Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial

16. Additional file 5 of Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial

17. Additional file 4 of Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial

18. Additional file 9 of Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial

19. Additional file 8 of Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial

20. COVID-19 Clinical Severity, T Cell-Mediated Immune Response, and Correlates of Inflammation: Not an Intuitive Guess

21. Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]

22. Fitness Cost of Antiretroviral Drug Resistance Mutations on the pol Gene during Analytical Antiretroviral Treatment Interruption among Individuals Experiencing Virological Failure

24. Immunogenicity of Personalized Dendritic-cell Therapy in HIV-1 Infected Individuals Under Suppressive Antiretroviral Treatment: Interim Analysis From a Phase II Clinical Trial.

26. Nitazoxanide In Vitro Efficacy Against SARS CoV-2 andIn Vivo Superiority to Placebo to Treat Moderate COVID-19 – A Phase 2 Randomized Double-Blind Clinical Trial

27. Picosecond-resolution soft-x-ray laser plasma interferometry

32. NASA Langley and AF RADC high-speed fiber optic transceiver program

33. Standard, multipurpose fiber optic transceivers (MFOX)

35. Coherence measurements of a transient 14.7-nm x-ray laser

37. Improved energy coupling into the gain region of the Ni-like Pd transient collisional x-ray laser

38. Interferometric studies of laser-created plasmas using compact soft x-ray lasers

39. Longitudinal coherence measurements of a transient collisional x-ray laser

42. Coherence measurements of a transient 14.7-nm x-ray laser.

43. Interferometric Diagnosis of Two-Dimensional Plasma Expansion.

44. Longitudinal Coherence Measurements of the Transient Collisional X-ray Laser.

45. Photoluminescence and Electroluminescence of Erbium and Neodymium Implanted Semiconductors.

Catalog

Books, media, physical & digital resources